Not yet investigated
What we have so far
The trials show no average benefit from adding T3 — and a subgroup carrying a DIO2 variant reports feeling better on it, which an average cannot see.
This star is on the map because the show intends to take the question apart properly — the trials, how it is actually tested, whether the thing sold is the thing studied. That work is not done yet, and nothing here should be read as a conclusion. When the investigation is published it will appear on this page.